Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Else Nutrition Holdings Inc T.BABY

Alternate Symbol(s):  T.BABY.WT.A | BABYF

Else Nutrition Holdings Inc is an Israel-based company active in field of food manufacturing. The Company focuses on research, development, manufacturing, marketing and sale of innovative plant-based food and nutrition products and also maintain feeding accessories products to infants and dried food snacks.


TSX:BABY - Post by User

Bullboard Posts
Post by Hiddensecretson Jun 13, 2020 12:41am
240 Views
Post# 31146106

Allergy Target Market: 2% to 3% of babies are allergic

Allergy Target Market: 2% to 3% of babies are allergicElse plans to launch powder and liquid formula products for toddlers (12 to 36 months old babies) in the U.S. market during the 2nd quarter of 2020, targeting initially parents of babies that suffer from allergies, and vegan families that prefer not to feed their babies with dairy products.

https://www.prnewswire.com/il/news-releases/else-nutrition-plant-based-food-startup-receives-huge-welcome-on-the-toronto-stock-exchange-300875292.html

Cow’s milk allergy (CMA) affects 2% to 3% of young children and presents with a wide range of immunoglobulin E (IgE-) and non-IgE-mediated clinical syndromes, which have a significant economic and lifestyle impact.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3070118/#:~:text=CONCLUSION,%2DIgE%2Dmediated%20clinical%20syndromes.

Number of toddlers in USA:    23 million 

Target Market for babies with cow allergies:   460,000 to 690,000

5% penetration:     Between 23,000 to 34,500 toddlers

Average cost per toddler:      $ 832 per year  (estimated if two cannesters per month $32 each)

Revenue potential on 5% market share:    $ 19,136,000 to $ 28,704,000

Present Market Cap:    $ 160,000,000

Sharing a bit of information, 

I am not accounting for any vegan families as this will be a tougher sell as they may be using soya. 

MPO  
Bullboard Posts